ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas

Ann Surg Oncol. 2020 Dec;27(Suppl 3):804-805. doi: 10.1245/s10434-020-08802-1. Epub 2020 Jul 1.

Authors

Robin Schmitz¹, Dimitrios Moris², John H Strickler³, Dan G Blazer 3rd²

Affiliations

¹ Department of Surgery, Duke University Medical Center, Durham, USA. robin.schmitz@duke.edu.
² Department of Surgery, Duke University Medical Center, Durham, USA.
³ Department of Medicine, Duke University Medical Center, Durham, USA.

PMID: 32613368
DOI: 10.1245/s10434-020-08802-1

No abstract available

MeSH terms

Carcinoma, Neuroendocrine* / drug therapy
Carcinoma, Neuroendocrine* / surgery
Humans
Neoplasms, Glandular and Epithelial
Neuroendocrine Tumors* / drug therapy
Neuroendocrine Tumors* / surgery
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery